HTG MOLECULAR DIAGNOSTICS IN
COM NEW · CUSIP 40434H203
0
institutional holders
-20 vs Q3 2022
—reported value*
0 new
0 added
0 reduced
19 sold out
net sold ≈ $283.0k (-464.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 20 |
| Q4 2022 | 0 |
Biggest buyers
| None |
Biggest sellers
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -86.4k |
| BlackRock Inc. | Sold out | -74.2k |
| Virtu Financial LLC | Sold out | -72.5k |
| VANGUARD GROUP INC | Sold out | -70.9k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -47.2k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -27.5k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -23.7k |
| TWO SIGMA SECURITIES, LLC | Sold out | -21.7k |
| STATE STREET CORP | Sold out | -14.5k |
| MORGAN STANLEY | Sold out | -10.6k |
Holders, Q4 2022
| Manager | Shares | Change |
|---|